Characteristics of Patients Experiencing Thromboembolic Events during Treatment for Multiple Myeloma: Aspirin May Not Be Adequate Thromboprophylaxis in Patients with Multiple Risk Factors.
Abstract:Patients (pts) with multiple myeloma (MM) have a high risk of venous thromboembolism (VTE) due to features of the disease or treatment, such as thalidomide (Thal), Lenalidomide (Len), steroids, and certain chemotherapeutic agents. Based on evidence showing the benefit of VTE pharmacological prophylaxis, it is recommended that VTE prophylaxis be prescribed for pts receiving these agents. However, the impact of these guidelines on patient outcomes is less well studied. The study aim was to evaluate the character… Show more
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.